Navigation Links
Insulet Reports Third Quarter 2008 Results
Date:11/6/2008

volume output of approximately 200,000 OmniPods per month in the third quarter.

-- As part of Insulet's efforts to further demonstrate the clinical and functional benefits of the OmniPod System and expand the market for its potential uses, the Company is supporting the first investigator initiated clinical trial of the OmniPod System to deliver concentrated U500 insulin to patients with Type 2 diabetes. The study, which completed enrollment in the third quarter, is being conducted by Dr. Wendy Lane at the Mountain Diabetes and Endocrine Center in Asheville, NC. The first subjects will complete the one-year trial in the fourth quarter of 2008 and the full study is expected to be completed in 2009.

Conference Call

Insulet will host a conference call on Thursday, November 6, 2008 at 5:00PM Eastern time to discuss the Company's third quarter 2008 results and present information concerning its business, strategies and outlook. To listen to the conference call, please dial 800-329-9097 for domestic callers and 617-614-4929 for international callers. The passcode is 94585068. A replay of the conference call will be available two hours after the start of the call through November 19, 2008 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 97337909. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.

Non-GAAP financial information

The Company reports both GAAP revenue and non-GAAP revenue. Non-GAAP revenue is equal to GAAP revenue excluding the impact of a change to the Company's estimate of deferred revenue. Prior to January 1, 2008, the Company deferred the revenue and related costs of revenue for all initial customer shipments until a 45-day right of return had lapsed. With the accumulation of approximately 2 years of data for sales and retu
'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... AvePoint Public Sector, Inc., a wholly ... and devices, today announced it was named the recipient of the 2015 GTRA ConVurge ... given out by the Government Technology Research Alliance (GTRA), was presented June 29 during ...
(Date:7/2/2015)... ... ... arrests and fatalities spike on the 4th of July. In fact, because of drunk drivers, ... to being on the road. According to attorney David J. Maloney , the statistics ... deaths between 2007 and 2011 were caused by drunk driving over the 4th of July ...
(Date:7/2/2015)... Yorba Lind, CA (PRWEB) , ... July 02, 2015 , ... ... Dunne, PhD, QC manager, have adopted Lean methodology in their QC laboratory for enhanced ... Certified Lean Six Sigma Laboratory within the GE Healthcare Diagnostic Imaging network. ...
(Date:7/2/2015)... ... 2015 , ... As part of the celebration of its 70th anniversary, the ... its patients from all around the world for their continuous patronage of the world-class ... a dental tour (indeed, Thantakit is one of the foremost places for dental tourism ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... with nutritionally based weight-loss programs , was named No. 14 on ColoradoBiz ... this is the third year SlimGenics has been recognized. The award identifies outstanding ...
Breaking Medicine News(10 mins):Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3
... , FRIDAY, Jan. 14 (HealthDay News) -- Researchers have ... risk of cardiovascular disease, while also noting that having ... once arteries become clogged. "Certain genes predispose to ... heart attack when you already have plaque build-up," said ...
... ongoing controversy about the appropriate age, frequency, and ... the upcoming 19th Annual Congress on Women,s Health, ... "Point-Counterpoint: The Mammography Controversy" will explore the relevant ... of Radiology, Magee-Womens Hospital, University of Pittsburgh School ...
... HealthDay Reporter , FRIDAY, Jan. 14 (HealthDay News) -- If ... you stand and sit may affect how you feel about ... an interview during these tough economic times, according to a ... Management at Northwestern University in Illinois found that undergraduates who ...
... -- Bacteria that prey on other bacteria may prove useful ... two types of predatory bacteria -- Micavibrio aeruginosavorus ... bacteria. "They actually have to consume other bacteria in ... ability to seek out other bacteria, invade them, grow in ...
... News) -- Obese black patients receive less weight reduction and ... study finds. The researchers at the Johns Hopkins University ... to find that white patients treated by black doctors were ... black patients treated by black doctors. "Our findings could ...
... , FRIDAY, Jan. 14 (HealthDay News) -- ... to become primary care doctors, who are expected to ... contends a new study from Johns Hopkins. They,re ... problems as diabetes, hypertension and high cholesterol, the study ...
Cached Medicine News:Health News:Blood Type O Associated With Less Risk for Heart Attack 2Health News:Blood Type O Associated With Less Risk for Heart Attack 3Health News:Mammography controversy to be explored at 19th Annual Congress on Women's Health 2Health News:To Nab That Job, Check Your Posture 2Health News:To Nab That Job, Check Your Posture 3Health News:Predatory Bacteria May Help Control Antibiotic-Resistant Germs 2Health News:Is Race a Factor in Obesity Counseling? 2Health News:Med School Grads May Not Be Ready for Primary Care 2
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... Making uninformed decisions in today,s new and ... kind of small missteps that briefly disrupt productivity ... negative media attention. Savvy pharmaceutical executives base direction-changing ... To support pharmaceutical vice presidents, directors, and ...
... UCB, a leading biopharmaceutical company at the forefront of ... Cimzia® (certolizumab pegol) at the American College of Gastroenterology ... from October 28 to November 2.   ... the role that inflammatory biomarkers may play in increasing ...
Cached Medicine Technology:Pharmaceutical Executives Use New Search Function for Data-Informed Decision-Making 2New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 2New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 3New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 4New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 5New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 6New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 7New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 8New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 9New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 10New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 11
For the quantitative determination of total protein in serum. Linearity: 1-15 g/dl....
For the determination of urea nitrogen in human serum....
... for the quantitative determination of ... kinetic, lag phase of less ... linear phase of at least ... Linearity: 100 mg/dL (35.6 mmol/L ...
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Medicine Products: